Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Level2View


CASI Pharmaceuticals To Present At Jefferies London Healthcare Conference


PR Newswire | Nov 15, 2021 07:01AM EST

11/15 06:00 CST

CASI Pharmaceuticals To Present At Jefferies London Healthcare Conference ROCKVILLE, Md., and BEIJING, Nov. 15, 2021

ROCKVILLE, Md., and BEIJING, Nov. 15, 2021 /PRNewswire/ -- CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a U.S. biopharmaceutical company focused on developing and commercializing innovative therapeutics and pharmaceutical products, today announces that Mr. Larry Zhang, President of CASI Pharmaceuticals, will be presenting at the Jefferies London Healthcare Conference. Details for the virtual conferenceis as follows:

Jefferies London Healthcare ConferenceDate: November 18th & 19thTime: On-Demand

Webcast or external link of the company presentations will be available under "Events & Presentations" in the "Investors Relations" section of CASI's website. Archived replays will be available for approximately 90 days following the event.

About CASI Pharmaceuticals

CASI Pharmaceuticals, Inc. is a U.S. biopharmaceutical company focused on developing and commercializing innovative therapeutics and pharmaceutical products in China, the United States, and throughout the world. The Company is focused on acquiring, developing and commercializing products that augment its hematology oncology therapeutic focus as well as other areas of unmet medical need. The Company intends to execute its plan to become a leader by launching medicines in the greater China market leveraging the Company's China-based regulatory and commercial competencies and its global drug development expertise. The Company's operations in China are conducted through its wholly-owned subsidiary, CASI Pharmaceuticals (China) Co., Ltd., which is located in Beijing, China. The Company has built a commercial team of more than 100 hematology oncology sales and marketing specialists based in China. More information on CASI is available at www.casipharmaceuticals.com.

INVESTOR CONTACT:COMPANY CONTACT: Bob AiCASI Pharmaceuticals, Inc. Solebury Trout240.864.2643 646-389-6658ir@casipharmaceuticals.com bai@soleburytrout.com

View original content to download multimedia: https://www.prnewswire.com/news-releases/casi-pharmaceuticals-to-present-at-jefferies-london-healthcare-conference-301423740.html

SOURCE CASI Pharmaceuticals, Inc.






Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2025 ChartExchange LLC